File Download

There are no files associated with this item.

Conference Paper: Advances in the Clinical Management of Nasopharyngeal Cancer

TitleAdvances in the Clinical Management of Nasopharyngeal Cancer
Authors
Issue Date2014
Citation
The 16th International Symposium on EBV and Associated Diseases, Brisbane, Australia, 16-19 July 2014 How to Cite?
AbstractNasopharyngeal carcinoma (NPC) is one of the most peculiar cancers with a distinctly skewed geographic and ethnic distribution. Epidemiological studies have unveiled its multifactorial etiology with a dynamic interplay of genetic predisposition, Epstein–Barr virus (EBV) infection and environmental carcinogens. Radiotherapy has been the mainstay of curative treatment. The use of highly precise intensity-modulation radiotherapy technique has achieved excellent locoregional control and reduced treatment toxicities. Combination chemotherapy with cisplatin-based regimen further improves treatment outcome. The refinement of radiotherapy technique, search for more potent systemic agents, contemporary treatment strategies for recurrent or metastatic diseases, biomarkers for prognostification and prediction of treatment response are currently under intense study.
DescriptionCelebrating 50 years of Epstein-Barr virus discovery (1964-2014)
Session 11: Clinical Aspects of EBV-associated malignancies
Persistent Identifierhttp://hdl.handle.net/10722/206038

 

DC FieldValueLanguage
dc.contributor.authorSze, CKHen_US
dc.contributor.authorLee, AWMen_US
dc.date.accessioned2014-10-20T11:44:40Z-
dc.date.available2014-10-20T11:44:40Z-
dc.date.issued2014en_US
dc.identifier.citationThe 16th International Symposium on EBV and Associated Diseases, Brisbane, Australia, 16-19 July 2014en_US
dc.identifier.urihttp://hdl.handle.net/10722/206038-
dc.descriptionCelebrating 50 years of Epstein-Barr virus discovery (1964-2014)-
dc.descriptionSession 11: Clinical Aspects of EBV-associated malignancies-
dc.description.abstractNasopharyngeal carcinoma (NPC) is one of the most peculiar cancers with a distinctly skewed geographic and ethnic distribution. Epidemiological studies have unveiled its multifactorial etiology with a dynamic interplay of genetic predisposition, Epstein–Barr virus (EBV) infection and environmental carcinogens. Radiotherapy has been the mainstay of curative treatment. The use of highly precise intensity-modulation radiotherapy technique has achieved excellent locoregional control and reduced treatment toxicities. Combination chemotherapy with cisplatin-based regimen further improves treatment outcome. The refinement of radiotherapy technique, search for more potent systemic agents, contemporary treatment strategies for recurrent or metastatic diseases, biomarkers for prognostification and prediction of treatment response are currently under intense study.en_US
dc.languageengen_US
dc.relation.ispartofInternational Symposium on EBV and Associated Diseasesen_US
dc.titleAdvances in the Clinical Management of Nasopharyngeal Canceren_US
dc.typeConference_Paperen_US
dc.identifier.emailSze, CKH: henrysze@graduate.hku.hken_US
dc.identifier.emailLee, AWM: awmlee@hkucc.hku.hken_US
dc.identifier.authoritySze, CKH=rp01697en_US
dc.identifier.hkuros241239en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats